Precigen, Inc. (PGEN) Cash Flow Statement
Precigen, Inc. (PGEN) generated -$114.2M of operating cash flow over the twelve months to 2026-06-30, spent $1.1M on capital expenditure and had free cash flow of -$115.2M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
PGENPrecigen, Inc.Follow PGEN — free
—
Price chart with a free account
- Market cap
- 2.2B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Nov, in 18 days
| Line | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -53.7 | -19.9 | 35.7 | -49.0 | -103.7 | -124.2 | -135.9 | -77.0 | -55.8 | -65.0 | -66.9 | -68.2 | -87.8 | -114.2 | |
| Capital expenditure | 1.5 | 6.4 | 12.7 | 31.6 | 46.7 | 41.6 | 37.9 | 7.5 | 7.2 | 4.9 | 1.5 | 8.6 | 2.0 | -1.1 | |
| Free cash flow | -55.2 | -26.2 | 22.9 | -80.6 | -150.4 | -165.8 | -173.8 | -84.5 | -63.0 | -70.0 | -68.5 | -76.8 | -89.8 | -115.2 | |
| Stock-based compensation | 2.9 | 21.8 | 38.7 | 42.2 | 41.6 | 36.3 | 19.0 | 18.4 | 13.9 | 10.2 | 9.9 | 9.5 | 10.9 | — |
USD millions · SEC XBRL
Precigen, Inc. — questions
- What is Precigen, Inc.'s operating cash flow?
- -$114.2M over the twelve months to 2026-06-30.
- How much does Precigen, Inc. spend on capital expenditure?
- $1.1M over the twelve months to 2026-06-30.
- What is Precigen, Inc.'s free cash flow?
- -$115.2M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Precigen, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.